Skip to Content

Join the 'Cortastat LA' group to help and get support from people like you.

Cortastat LA Support Group

Further Information

Related Condition Support Groups

Adrenal Insufficiency, Inflammatory Conditions, Nausea / Vomiting - Chemotherapy Induced, Addison's Disease, Adrenocortical Insufficiency, Hay Fever, Allergic Rhinitis, Aspiration Pneumonia, Iritis, view more... Cerebral Edema, Asthma, Bursitis, Lymphoma, Mountain Sickness / Altitude Sickness, Epicondylitis - Tennis Elbow, Multiple Myeloma, Ulcerative Colitis, Idiopathic (Immune) Thrombocytopenic Purpura, Uveitis (Posterior), Eczema, Ankylosing Spondylitis, Asthma - Acute, Adrenogenital Syndrome, Tuberculous Meningitis, Pulmonary Tuberculosis, Mycosis Fungoides, Neurosarcoidosis, Pemphigus, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Transverse Myelitis, Multiple Sclerosis, Seborrheic Dermatitis, Shock, Synovitis, Systemic Lupus Erythematosus, Thrombocytopenia, Toxic Epidermal Necrolysis, Sarcoidosis, Aphthous Ulcer, Dermatitis Herpetiformis, Iridocyclitis, Erythroblastopenia, Evan's Syndrome, Gouty Arthritis, Hemolytic Anemia, Hypercalcemia of Malignancy, Cushing's Syndrome, Inflammatory Bowel Disease, Croup, Chorioretinitis, Meningitis - Pneumococcal, Juvenile Rheumatoid Arthritis, Bronchopulmonary Dysplasia, Leukemia, Loeffler's Syndrome, Contact Dermatitis, Atopic Dermatitis, Meningitis - Haemophilus influenzae, Meningitis - Listeriosis, Meningitis - Meningococcal, Keratitis

Related Drug Support Groups

Decadron, Decadron Tablets, Dexone, Adrenocot, Adrenocot LA, Cortastat, Cortastat 10, De-Sone LA, Dexone LA, view more... Cortastat LA, Dexpak Taperpak, Decadron 5-12 Pak, Decadron Dose Pack, Decadron-LA, Decaject, Decaject LA, Baycadron, Medidex, Medidex LA, Primethasone, Dexamethasone Intensol, Zonacort, Dalalone, Dalalone DP, LoCort, Dalalone LA, Zema Pak, Dexacen-4, Dexacort-LA, Dexacorten, Dexasone, Dexasone LA, Solurex, Solurex LA, Hexadrol, Hexadrol Phosphate

Cortastat LA Patient Information at

Latest News

Imbruvica Approval Expanded to Include Graft Versus Host Disease

WEDNESDAY, Aug. 2, 2017 – The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease ...

Read more news...

Ask a Question